Las Vegas, NV -- (SBWIRE) -- 09/23/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Wilshire Bancorp Inc (NASDAQ:WIBC), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) managed to keep its gain at 2.55% on above-normal volume of 3M shares. The stock settled at $11.06 after floating in a range of $10.42 to $11.11. Its latest price has reached market capitalization of $741.71 million. Its 52-week range has been $6.72 to $16.74.
Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
For How Long NBIX will fight for Profitability? Read This Trend Analysis report
Halozyme Therapeutics, Inc. (NASDAQ:HALO) traded down on a volume of 2.26 million, higher than its standard daily volume. Shares have dropped-2.67% to $9.83. Over the last twelve months, the stock has gained 23.65% and faced a worst price of $4.80.
Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
Has HALO Found The Bottom And Ready To Gain Momentum? Find Out Here
Wilshire Bancorp Inc (NASDAQ:WIBC) settled 0.49% higher at $8.28 on above-normal volume of 3.47M shares during the last trading day. The stock has its 12-month high at $9.05 and 52-week low price was $5.35. It traded in a range of $8.21 to $8.51 during the last trading day.
Wilshire Bancorp, Inc. operates as the holding company for Wilshire State Bank that offers a range of financial products and services. The company operates in three segments: Banking Operations,
Will WIBC Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Merrimack Pharmaceuticals Inc (NASDAQ:MACK) was down on high volume, trading at a volume of 2.40M shares versus its average daily volume of 2.05 million shares. At $3.82, the stock has attained market capitalization of $390.44 million.
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Why Should Investors Buy MACK After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)